Skip to main content
Skip to content
Case File
efta-efta00365543DOJ Data Set 9Other

From: Lesley Groff

Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00365543
Pages
2
Persons
0
Integrity
No Hash Available

Summary

Ask AI About This Document

0Share
PostReddit

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Lesley Groff To: Jeffrey Epstein <[email protected]> Subject: Fwd: Vesselon Overview Documents Date: Mon, 11 Aug 2014 11:49:42 +0000 Sent from my iPhone Begin forwarded message: From: "Don Spongberg" < Date: August 8, 2014, 12:03:45 PM EDT To: Subject: Vesselon Overview Documents Reply-To: "Don Spongberg" Dear Jeffrey, I am pleased to present the market collateral for Vesselon, Inc. • Executive Overview • One Page Overview • Investor Presentation Vessebn is a development stage company that is developing and will seek to market the world's first portable devices for the immediate treatment of ischemic stroke — the most common type of stroke, which occurs when a blood vessel supplying blood to the brain is blocked by a blood clot. Vessebn believes their potential device, which can be compared to an automated external defibrillator ("AED") for stroke, is distinct from all current or experimental therapies. Their noninvasive device is aimed to treat ischemic stroke victims by working to dissolve blood clots before or as victims arrive at a hospital - critical because minutes matter to save lives. Prolonged delay in restoring blood flow to affected areas of the brain after an ischemic stroke may result in severe or permanent incapacitation, paralysis, loss of speech or cognitive function. Just as AEDs now save cardiac arrest patients' lives, Vesselon believes their proposed immediate ischemic stroke treatment device has the potential to save lives, improve patient outcomes and reduce healthcare costs. I look forward to speaking with you further about the Vesselon opportunity. I will be pleased to provide you with a copy of the confidential Private Placement Memorandum upon request. EFTA00365543 Don Spongberg Senior Managing Director Spencer Trask Ventures Member FINRA & SIPC INVESTMENTS IN THIS OFFERING SHALL BE RESTRICTED SOLELY TO ACCREDITED INVESTORS THAT HAVE BEEN VERIFIED BY THE COMPANY AND THE PLACEMENT AGENT IN ACCORDANCE WITH RULE 506(C) UNDER THE SECURITIES ACT OF 1933. AS AMENDED. FOR INFORMATION PURPOSES ONLY. The information contained herein does not constitute an offer to sell or a solicitation of an offer to buy any security in Vesselon. Inc. (the 'Company'). An offer can be made only pursuant to the Confidential Private Placement Memorandum of the Company. and only in stales in which the offering of the securities is registered. or is exempt from registration and only by broker-dealers authorized to do so. To the extent an inconsistency exists between this material and the Company's Confidential Private Placement Memorandum. dated July 30.2014. as the same may be amended. supplemented or otherwise modified from time to time (the -PPM"). the disclosure in the PPM shall control. Click here to manage your email subscriptions. View the online version of this email. Spencer Trask Ventures. Inc. Member F/NRA & SIPC 1140 Avenue of the Americas. 9th Floor. New York. NY 10036 1700 East Putnam Avenue. Suite 302. Old Greenwich. CT 06870 EFTA00365544

Technical Artifacts (1)

View in Artifacts Browser

Email addresses, URLs, phone numbers, and other technical indicators extracted from this document.

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.